Treatment Insulin Resistence in HCV G-1 Patient

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

January 31, 2007

Conditions
Chronic Hepatitis C
Interventions
DRUG

Metformine

850-2550 mg/daily for 48 weeks

OTHER

Placebo of metformine

850-2550 mg/daily for 48 weeks

Trial Locations (19)

13005

Hospital General de Ciudad Real, Ciudad Real

14004

Hospital Reina Sofía, Córdoba

18003

Hospital Clínico Universitario San Cecilio, Granada

18004

Hospital Virgen de las Nieves, Granada

20014

Hospital de Donostia, Donostia / San Sebastian

24071

Hospital de Leon, León

28006

Hospital de la Princesa, Madrid

28007

Hospital Gregorio Marañón, Madrid

28029

Hospital Carlos III, Madrid

28035

Hospital Puerta de Hierro, Madrid

28046

Hospital La Paz, Madrid

28922

Fundación Hospital de Alcorcón, Alcorcón

29010

Hospital Universitario Virgen de la Victoria, Málaga

41009

Hospital Virgen Macarena, Seville

41014

Hospital Universitario de Valme, Seville

46014

Hospital General Universitario, Valencia

08916

Hospital Germans Trias i Pujol, Badalona

08003

Hospital del Mar, Barcelona

08208

Hospital Parc Taulí, Sabadell

All Listed Sponsors
lead

Valme University Hospital

OTHER

NCT00546442 - Treatment Insulin Resistence in HCV G-1 Patient | Biotech Hunter | Biotech Hunter